On the recordMay 30, 2026
Decades after FDA’s initial approval of mifepristone and years after the in-person dispensing requirement was eliminated, the Fifth Circuit on an ‘emergency’ basis ordered FDA to re-impose this onerous nationwide restriction on all Americans.
Source
duckworth.senate.gov




